{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:40:45Z","timestamp":1787668845411,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI13C1874"],"award-info":[{"award-number":["HI13C1874"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.bone.2019.115056","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T15:02:44Z","timestamp":1567263764000},"page":"115056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts"],"prefix":"10.1016","volume":"129","author":[{"given":"Suk Hee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeen-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.115056_bb0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI33612","article-title":"Building bone to reverse osteoporosis and repair fractures","volume":"118","author":"Khosla","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2019.115056_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bone.2019.115056_bb0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beem.2008.07.006","article-title":"Bone remodelling: its local regulation and the emergence of bone fragility","volume":"22","author":"Martin","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.115056_bb0020","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","article-title":"Cellular and molecular mechanisms of bone remodeling","volume":"285","author":"Raggatt","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.115056_bb0025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2019.115056_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0011-2015","article-title":"Osteoclasts-key players in skeletal health and disease","volume":"4","author":"Novack","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bone.2019.115056_bb0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbadis.2009.05.004","article-title":"Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions","volume":"1792","author":"Everts","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bone.2019.115056_bb0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2019.115056_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00223-014-9865-4","article-title":"A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation","volume":"95","author":"Thudium","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2019.115056_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/er.2010-0006","article-title":"Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis","volume":"32","author":"Henriksen","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2019.115056_bb0055","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality \u2014 the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2019.115056_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","article-title":"Osteoblast-osteoclast interactions","volume":"59","author":"Chen","year":"2018","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.bone.2019.115056_bb0065","doi-asserted-by":"crossref","first-page":"23971","DOI":"10.1074\/jbc.M302457200","article-title":"Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-\u03baB ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2\u2212\/\u2212 mice by RANKL transgene","volume":"278","author":"Enomoto","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.115056_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcp.20036","article-title":"Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation","volume":"200","author":"Karst","year":"2004","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2019.115056_bb0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bone.2019.115056_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/er.2017-00064","article-title":"Energy metabolism of the osteoblast: implications for osteoporosis","volume":"38","author":"Lee","year":"2017","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2019.115056_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s13238-017-0385-7","article-title":"The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells","volume":"8","author":"Li","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.bone.2019.115056_bb0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/scd.2015.0193","article-title":"Energy metabolism in mesenchymal stem cells during osteogenic differentiation","volume":"25","author":"Shum","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bone.2019.115056_bb0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bone.2010.04.593","article-title":"Enhanced mitochondrial biogenesis contributes to Wnt induced osteoblastic differentiation of C3H10T1\/2 cells","volume":"47","author":"An","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.115056_bb0100","doi-asserted-by":"crossref","first-page":"C1220","DOI":"10.1152\/ajpcell.2000.279.4.C1220","article-title":"Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts","volume":"279","author":"Komarova","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bone.2019.115056_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jb\/mvv112","article-title":"The role of osteoclast differentiation and function in skeletal homeostasis","volume":"159","author":"Ikeda","year":"2016","journal-title":"J. Biochem."},{"key":"10.1016\/j.bone.2019.115056_bb0110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biocel.2016.08.034","article-title":"Energy metabolism in osteoclast formation and activity","volume":"79","author":"Lemma","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bone.2019.115056_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10545-017-0046-2","article-title":"Risk factors for poor bone health in primary mitochondrial disease","volume":"40","author":"Gandhi","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2019.115056_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbrc.2017.09.045","article-title":"Direct effects of mitochondrial dysfunction on poor bone health in Leigh syndrome","volume":"493","author":"Kato","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2019.115056_bb0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/jcp.51.2.117","article-title":"Age related somatic mitochondrial DNA deletions in bone","volume":"51","author":"Papiha","year":"1998","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bone.2019.115056_bb0130","doi-asserted-by":"crossref","first-page":"12116","DOI":"10.1016\/S0021-9258(19)50315-5","article-title":"Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenases","volume":"268","author":"Haselbeck","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.115056_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-5793(94)00370-X","article-title":"Proton-translocating transhydrogenase and NAD- and NADP-linked isocitrate dehydrogenases operate in a substrate cycle which contributes to fine regulation of the tricarboxylic acid cycle activity in mitochondria","volume":"344","author":"Sazanov","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bone.2019.115056_bb0140","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1016\/j.bbagen.2013.07.013","article-title":"Knockdown of both mitochondrial isocitrate dehydrogenase enzymes in pancreatic beta cells inhibits insulin secretion","volume":"1830","author":"MacDonald","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bone.2019.115056_bb0145","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1074\/jbc.M010120200","article-title":"Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase","volume":"276","author":"Jo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.115056_bb0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2014.12.018","article-title":"IDH2 deficiency promotes mitochondrial dysfunction and cardiac hypertrophy in mice","volume":"80","author":"Ku","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bone.2019.115056_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbrc.2017.09.082","article-title":"Idh2 deficiency accelerates renal dysfunction in aged mice","volume":"493","author":"Lee","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2019.115056_bb0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/10715762.2016.1185519","article-title":"IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson\u2019s disease","volume":"50","author":"Kim","year":"2016","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bone.2019.115056_bb0165","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.coph.2010.01.003","article-title":"Purinergic signalling and bone remodelling","volume":"10","author":"Orriss","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bone.2019.115056_bb0170","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/dgd.12288","article-title":"Adenosine triphosphate stimulates differentiation and mineralization in human osteoblast-like Saos-2 cells","volume":"58","author":"Cutarelli","year":"2016","journal-title":"Develop. Growth Differ."},{"key":"10.1016\/j.bone.2019.115056_bb0175","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.biocel.2006.05.018","article-title":"Modulation of ERK 1\/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation","volume":"38","author":"Katz","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bone.2019.115056_bb0180","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","article-title":"A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation","volume":"106","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bone.2019.115056_bb0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3858\/emm.2011.43.11.067","article-title":"Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species","volume":"43","author":"Moon","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bone.2019.115056_bb0190","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1177\/0748233713491801","article-title":"Reactive oxygen species induce cell death via Akt signaling in rat osteoblast-like cell line ROS 17\/2.8","volume":"31","author":"Zhang","year":"2015","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.bone.2019.115056_bb0195","doi-asserted-by":"crossref","first-page":"14692","DOI":"10.1074\/jbc.M114.633461","article-title":"p47phox-Nox2-dependent ROS signaling inhibits early bone development in mice but protects against skeletal aging","volume":"290","author":"Chen","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.115056_bb0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2220\/biomedres.34.161","article-title":"Involvement of reactive oxygen species in osteoblastic differentiation of MC3T3-E1 cells accompanied by mitochondrial morphological dynamics","volume":"34","author":"Arakaki","year":"2013","journal-title":"Biomed. Res."},{"key":"10.1016\/j.bone.2019.115056_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2016.08.011","article-title":"Increased obesity resistance and insulin sensitivity in mice lacking the isocitrate dehydrogenase 2 gene","volume":"99","author":"Lee","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bone.2019.115056_bb0210","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1172\/JCI26132","article-title":"M-CSF mediates TNF-induced inflammatory osteolysis","volume":"115","author":"Kitaura","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2019.115056_bb0215","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00210-0","article-title":"Osteoblasts\/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor\/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand","volume":"25","author":"Udagawa","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.115056_bb0220","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/endo.141.9.7634","article-title":"Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function","volume":"141","author":"Udagawa","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2019.115056_bb0225","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.0105-2896.2009.00849.x","article-title":"Transcriptional regulation of bone and joint remodeling by NFAT","volume":"233","author":"Sitara","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bone.2019.115056_bb0230","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2019.115056_bb0235","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1074\/jbc.M213067200","article-title":"The Calcineurin\/nuclear factor of activated T cells signaling pathway regulates Osteoclastogenesis in RAW264.7 cells","volume":"279","author":"Hirotani","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.115056_bb0240","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","article-title":"Calcineurin\/NFAT signaling in osteoblasts regulates bone mass","volume":"10","author":"Winslow","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2019.115056_bb0245","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3390\/ijms18102204","article-title":"Isoproterenol increases RANKL expression in a ATF4\/NFATc1-dependent manner in mouse osteoblastic cells","volume":"18","author":"Baek","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2019.115056_bb0250","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jcp.24790","article-title":"The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells","volume":"230","author":"Park","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2019.115056_bb0255","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/MCB.00356-06","article-title":"Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer","volume":"26","author":"Fu","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2019.115056_bb0260","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1210\/me.2006-0315","article-title":"Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase a activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers","volume":"21","author":"Kim","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2019.115056_bb0265","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tibs.2010.04.002","article-title":"Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes","volume":"35","author":"Hamanaka","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bone.2019.115056_bb0270","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","article-title":"Mitochondrial ROS signaling in organismal homeostasis","volume":"163","author":"Shadel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bone.2019.115056_bb0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/13510002.2015.1135581","article-title":"Downregulation of IDH2 exacerbates H2O2 -mediated cell death and hypertrophy","volume":"22","author":"Ku","year":"2017","journal-title":"Redox Rep."},{"key":"10.1016\/j.bone.2019.115056_bb0280","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.redox.2018.04.008","article-title":"IDH2 deficiency accelerates skin pigmentation in mice via enhancing melanogenesis","volume":"17","author":"Park","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bone.2019.115056_bb0285","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","article-title":"Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes","volume":"62","author":"Etchegaray","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bone.2019.115056_bb0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","article-title":"Influence of metabolism on epigenetics and disease","volume":"153","author":"Kaelin","year":"2013","journal-title":"Cell"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219303461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219303461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T22:16:49Z","timestamp":1610921809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219303461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":58,"alternative-id":["S8756328219303461"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.115056","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.115056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115056"}}